Insider · CIK 0001940120
Tien-Li Lee
Files at AARD (Aardvark Therapeutics, Inc.). First filing Feb 19, 2025, latest Dec 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AARD: Aardvark Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Aardvark Therapeutics, Inc. | $101k 7,000 shares | +0% | +123% from low-10% from high | |
| 51Moderate | Aardvark Therapeutics, Inc. | $97k 10,000 shares | +1% | +42% from low-42% from high | |
| 52Moderate | Aardvark Therapeutics, Inc. | $161k 20,000 shares | +1% | +14% from low-54% from high | |
| 53Moderate | Aardvark Therapeutics, Inc. | $265k 16,542 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | AARD Aardvark Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | -203,851 | $0.00 | $0 | 203,851 | Feb 11, 2026 |
| Dec 11, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +7,000 | $14.49 | $101k | 1,551,613 | Dec 12, 2025 |
| Oct 15, 2025 | AARD Aardvark Therapeutics, Inc. | MOption exercise Common Stock | +1,229 | $4.24 | $5,211 | 1,544,613 | Oct 16, 2025 |
| Oct 15, 2025 | AARD Aardvark Therapeutics, Inc. | MOption exercise Stock option (right to buy)derivative | -1,229 | $0.00 | $0 | 40,566 | Oct 16, 2025 |
| Sep 15, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +6,500 | $9.51 | $62k | 1,539,884 | Sep 16, 2025 |
| Sep 15, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +3,500 | $9.94 | $35k | 1,543,384 | Sep 16, 2025 |
| Sep 10, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +9,000 | $7.91 | $71k | 1,522,384 | Sep 12, 2025 |
| Sep 11, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +6,000 | $7.82 | $47k | 1,528,384 | Sep 12, 2025 |
| Sep 12, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +5,000 | $8.50 | $43k | 1,533,384 | Sep 12, 2025 |
| Aug 28, 2025 | AARD Aardvark Therapeutics, Inc. | MOption exercise Common Stock | +17,209 | $4.24 | $73k | 1,513,384 | Aug 29, 2025 |
| Aug 28, 2025 | AARD Aardvark Therapeutics, Inc. | MOption exercise Stock option (right to buy)derivative | -17,209 | $0.00 | $0 | 41,795 | Aug 29, 2025 |
| Jun 11, 2025 | AARD Aardvark Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +549,534 | $0.00 | $0 | 549,534 | Jun 13, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stock | +41,303 | - | - | 1,479,633 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +16,542 | $16.00 | $265k | 1,496,175 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series A Convertible Preferred Stockderivative | -350,002 | $0.00 | $0 | 0 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.